AJP - Endocrinology and Metabolism, Vol 273, Issue 3 E514-E520, Copyright © 1997 by American Physiological Society

ARTICLES

More marked stimulation by lithium than insulin of the glycogenic pathway in rat skeletal muscle

C. Furnsinn, C. Noe, R. Herdlicka, M. Roden, P. Nowotny, B. Leighton and W. Waldhausl
Department of Medicine III, University of Vienna, Austria.

Lithium's impact on glucose metabolism was compared with that of insulin in isolated rat soleus muscle. Lithium chloride (20 mmol/l) induced a 4.8-fold more pronounced increment over basal glycogen synthase activity than insulin (10 nmol/l) (nmol UDP-glucose into glycogen in synthase activity assay.g-1.min-1: lithium, +22.1 +/- 1.8 vs. insulin, +4.6 +/- 3.9; P < 0.01). In parallel, lithium was less efficient than insulin in stimulating glucose transport (counts per minute 2-deoxy-D-[3H]glucose.mg-1.h-1: lithium, +211 +/- 19 vs. insulin, +311 +/- 57; P < 0.05) and lactate release (mumol.g-1.h-1: lithium, +1.0 +/- 0.5 vs. insulin, +3.9 +/- 0.5; P < 0.01), and similar increments were induced in glycogen synthesis (mumol glucose into glycogen.g-1.h-1: lithium, +3.32 +/- 0.43 vs. insulin, +3.46 +/- 0.47; not significant). Full additivity of glycogenic effects and divergent dependency on phosphatidylinositol 3-kinase activation provided further evidence for different mechanisms of action. In muscle from insulin-resistant obese Zucker rats (fa/fa), failure of lithium to reverse deficits in glucose metabolism suggested a primary deficit in muscle glucose uptake rather than glycogen synthesis. Hence lithium distinctly stimulates glycogen synthase activity in skeletal muscle and may therefore be regarded as a candidate for the treatment of disorders associated with primary deficits in the glycogenic pathway.

This article has been cited by other articles:

				D. B. Ring, K. W. Johnson, E. J. Henriksen, J. M. Nuss, D. Goff, T. R. Kinnick, S. T. Ma, J. W. Reeder, I. Samuels, T. Slabiak, et al. Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo Diabetes, March 1, 2003; 52(3): 588 - 595. [Abstract] [Full Text] [PDF]

				G. W. Cline, K. Johnson, W. Regittnig, P. Perret, E. Tozzo, L. Xiao, C. Damico, and G. I. Shulman Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (fa/fa) Rats Diabetes, October 1, 2002; 51(10): 2903 - 2910. [Abstract] [Full Text] [PDF]

				S. E. Nikoulina, T. P. Ciaraldi, S. Mudaliar, L. Carter, K. Johnson, and R. R. Henry Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle Diabetes, July 1, 2002; 51(7): 2190 - 2198. [Abstract] [Full Text] [PDF]

				N. HAUGAARD Reflections on the Role of the Thiol Group in Biology Ann. N.Y. Acad. Sci., January 1, 2000; 899(1): 148 - 158. [Abstract] [Full Text] [PDF]

				J. F. Markuns, J. F. P. Wojtaszewski, and L. J. Goodyear Insulin and Exercise Decrease Glycogen Synthase Kinase-3 Activity by Different Mechanisms in Rat Skeletal Muscle J. Biol. Chem., August 27, 1999; 274(35): 24896 - 24900. [Abstract] [Full Text] [PDF]

				S. J. Orena, A. J. Torchia, and R. S. Garofalo Inhibition of Glycogen-synthase Kinase 3 Stimulates Glycogen Synthase and Glucose Transport by Distinct Mechanisms in 3T3-L1 Adipocytes J. Biol. Chem., May 19, 2000; 275(21): 15765 - 15772. [Abstract] [Full Text] [PDF]